Discover essential updates from Innate Pharma S.A.'s Form 6-K filed on February 17, 2025, including SEC registration details and significant press releases.
Innate Pharma S.A. files Form 6-K with SEC, detailing corporate governance, regulatory compliance, and ongoing reporting commitments as of January 16, 2025.
Explore Innate Pharma S.A.'s January 10, 2025 SEC Form 6-K filing, featuring CEO insights and annual report details.
Discover Innate Pharma S.A.'s latest Form 6-K report on regulatory compliance and operational insights as of December 20, 2024, signed by CEO Jonathan Dickinson.